Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Accured Expenses (2019 - 2023)

Historic Change in Accured Expenses for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $2.0 million.

  • ADC Therapeutics' Change in Accured Expenses fell 8790.74% to $2.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$14.1 million, marking a year-over-year decrease of 22957.0%. This contributed to the annual value of $11.1 million for FY2024, which is 17876.69% up from last year.
  • Latest data reveals that ADC Therapeutics reported Change in Accured Expenses of $2.0 million as of Q4 2023, which was down 8790.74% from -$519000.0 recorded in Q3 2023.
  • ADC Therapeutics' 5-year Change in Accured Expenses high stood at $16.2 million for Q4 2022, and its period low was -$12.3 million during Q1 2023.
  • In the last 5 years, ADC Therapeutics' Change in Accured Expenses had a median value of $217.0 in 2019 and averaged -$268506.1.
  • Per our database at Business Quant, ADC Therapeutics' Change in Accured Expenses skyrocketed by 60560.75% in 2020 and then crashed by 958464.91% in 2023.
  • Over the past 5 years, ADC Therapeutics' Change in Accured Expenses (Quarter) stood at $921.0 in 2019, then crashed by 41.26% to $541.0 in 2020, then tumbled by 985682.26% to -$5.3 million in 2021, then skyrocketed by 404.6% to $16.2 million in 2022, then crashed by 87.91% to $2.0 million in 2023.
  • Its Change in Accured Expenses stands at $2.0 million for Q4 2023, versus -$519000.0 for Q3 2023 and -$3.3 million for Q2 2023.